The STING Signaling: A Novel Target for Central Nervous System Diseases

被引：0

作者：

Min Song ^{[1
]}

Jianxun Ren ^{[1
]}

Zhipeng Zhu ^{[1
]}

Zhaohui Yi ^{[2
]}

Chengyun Wang ^{[1
]}

Lirong Liang ^{[1
]}

Jiahui Tian ^{[1
]}

Guofu Mao ^{[1
]}

Guohua Mao ^{[1
]}

Min Chen ^{[1
]}

机构：

[1] Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.1 Minde Road, Jiangxi, Nanchang

[2] Department of Neurosurgery, Shangrao People’s Hospital, Shangrao, Jiangxi Province

来源：

Cellular and Molecular Neurobiology | / 45卷 / 1期

基金：

中国国家自然科学基金;

关键词：

Central nervous system; cGAS-STING; Drug delivery; STING; STING modulators;

D O I：

10.1007/s10571-025-01550-4

中图分类号：

学科分类号：

摘要：

The canonical cyclic GMP-AMP (cGAMP) synthase (cGAS)-Stimulator of Interferon Genes (STING) pathway has been widely recognized as a crucial mediator of inflammation in many diseases, including tumors, infections, and tissue damage. STING signaling can also be activated in a cGAS- or cGAMP-independent manner, although the specific mechanisms remain unclear. In-depth studies on the structural and molecular biology of the STING pathway have led to the development of therapeutic strategies involving STING modulators and their targeted delivery. These strategies may effectively penetrate the blood–brain barrier (BBB) and target STING signaling in multiple central nervous system (CNS) diseases in humans. In this review, we outline both canonical and non-canonical pathways of STING activation and describe the general mechanisms and associations between STING activity and CNS diseases. Finally, we discuss the prospects for the targeted delivery and clinical application of STING agonists and inhibitors, highlighting the STING signaling pathway as a novel therapeutic target in CNS diseases. © The Author(s) 2025.

引用

共 127 条

[1] Abdullah A., Zhang M., Frugier T., Bedoui S., Taylor J.M., Crack P.J., STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury, J Neuroinflammation, 15, 1, (2018)
[2] Abe T., Barber G.N., Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1, J Virol, 88, 10, pp. 5328-5341, (2014)
[3] Aguado J., Chaggar H.K., Gomez-Inclan C., Shaker M.R., Leeson H.C., Mackay-Sim A., Wolvetang E.J., Inhibition of the cGAS-STING pathway ameliorates the premature senescence hallmarks of Ataxia-Telangiectasia brain organoids, Aging Cell, 20, 9, (2021)
[4] Bahr O., Gross S., Harter P.N., Kirches E., Mawrin C., Steinbach J.P., Mittelbronn M., ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors, Oncol Lett, 14, 5, pp. 5443-5451, (2017)
[5] Bakhoum S.F., Ngo B., Laughney A.M., Cavallo J.A., Murphy C.J., Ly P., Shah P., Sriram R.K., Watkins T.B.K., Taunk N.K., Duran M., Pauli C., Shaw C., Chadalavada K., Rajasekhar V.K., Genovese G., Venkatesan S., Birkbak N.J., McGranahan N., Lundquist M., LaPlant Q., Healey J.H., Elemento O., Chung C.H., Lee N.Y., Imielenski M., Nanjangud G., Pe'er D., Cleveland D.W., Powell S.N., Lammerding J., Swanton C., Cantley L.C., Chromosomal instability drives metastasis through a cytosolic DNA response,
[6] Bao P., Gu H.Y., Ye J.J., He J.L., Zhong Z., Yu A.X., Zhang X.Z., Chimeric exosomes functionalized with STING activation for personalized glioblastoma immunotherapy, Adv Sci (Weinh), 11, 6, (2024)
[7] Barrett J.P., Knoblach S.M., Bhattacharya S., Gordish-Dressman H., Stoica B.A., Loane D.J., Traumatic brain injury induces cGAS activation and type I interferon signaling in aged mice, Front Immunol, 12, (2021)
[8] Bielecki P.A., Lorkowski M.E., Becicka W.M., Atukorale P.U., Moon T.J., Zhang Y., Wiese M., Covarrubias G., Ravichandran S., Karathanasis E., Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors, Nanoscale Horiz, 6, 2, pp. 156-167, (2021)
[9] Bodda C., Reinert L.S., Fruhwurth S., Richardo T., Sun C., Zhang B.C., Kalamvoki M., Pohlmann A., Mogensen T.H., Bergstrom P., Agholme L., O'Hare P., Sodeik B., Gyrd-Hansen M., Zetterberg H., Paludan S.R., HSV1 VP1–2 deubiquitinates STING to block type I interferon expression and promote brain infection, J Exp Med, (2020)
[10] Boudreau C.E., Najem H., Ott M., Horbinski C., Fang D., DeRay C.M., Levine J.M., Curran M.A., Heimberger A.B., Intratumoral delivery of STING agonist results in clinical responses in canine glioblastoma, Clin Cancer Res, 27, 20, pp. 5528-5535, (2021)

← 1 2 3 4 5 6 7 8 9 10 →